WeVote
Log In

Bill

Bill

SB 1186

Practice of pharmacy; designating certain drug as over-the-counter. Effective date.

2026 Regular Session Introduced by Stacy Adams and 1 co-sponsor

Oklahoma bill designates an unspecified medication as over-the-counter, removing prescription requirement and reducing physician oversight access barriers.

Second Reading referred to Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 1186

Legislative bill overview

SB 1186 modifies Oklahoma pharmacy practice laws to designate a specific drug as available over-the-counter rather than requiring a prescription. The bill appears to be in early legislative stages, having recently been referred to the Health and Human Services committee for consideration. The exact drug in question is not specified in the available summary information.

Why is this important

Over-the-counter designation changes reduce barriers to medication access by eliminating the need for doctor visits and prescriptions, potentially lowering healthcare costs for patients. However, such changes also affect pharmacy operations, insurance coverage, and public health considerations around medication safety and appropriate use without professional guidance.

Potential points of contention

  • Drug safety concerns: Moving medications from prescription to OTC status removes professional oversight; opponents may worry about misuse, drug interactions, or use in inappropriate populations
  • Pharmacy economics and professional scope: Pharmacists and pharmacy organizations may have competing interests regarding which drugs should require their consultation services
  • Insurance and cost implications: OTC designation typically means medications are no longer covered by insurance, shifting costs entirely to consumers despite potential public health benefits

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.